Gene · 5244
Papers3,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hypoglycemia and jaundice in newborns with pituitary stalk interruption syndrome. | Medicine (Baltimore) | 2021 | 34106625 | PubTator, text mining | PubMed |
| Clinical spectrum of chronic liver disease with final outcome in children at a tertiary centre: A single - centre study. | Pak J Med Sci | 2021 | 34104147 | PubTator, text mining | PubMed |
| Maternal bile acid profile and subtype analysis of intrahepatic cholestasis of pregnancy. | Orphanet J Rare Dis | 2021 | 34098996 | PubTator, text mining | PubMed |
| Epidemiology and burden of progressive familial intrahepatic cholestasis: a systematic review. | Orphanet J Rare Dis | 2021 | 34082807 | PubTator, text mining | PubMed |
| Mechanistic Insight into Antimicrobial and Antioxidant Potential of Jasminum Species: A Herbal Approach for Disease Management. | Plants (Basel) | 2021 | 34071621 | PubTator, text mining | PubMed |
| Malaria in the 'Omics Era'. | Genes (Basel) | 2021 | 34070769 | PubTator, text mining | PubMed |
| The Food Contaminants Pyrrolizidine Alkaloids Disturb Bile Acid Homeostasis Structure-Dependently in the Human Hepatoma Cell Line HepaRG. | Foods | 2021 | 34069968 | PubTator, text mining | PubMed |
| Statin as a Potential Chemotherapeutic Agent: Current Updates as a Monotherapy, Combination Therapy, and Treatment for Anti-Cancer Drug Resistance. | Pharmaceuticals (Basel) | 2021 | 34065757 | PubTator, text mining | PubMed |
| Current State of SLC and ABC Transporters in the Skin and Their Relation to Sweat Metabolites and Skin Diseases. | Proteomes | 2021 | 34065737 | PubTator, text mining | PubMed |
| Fibrotic Events in the Progression of Cholestatic Liver Disease. | Cells | 2021 | 34062960 | PubTator, text mining | PubMed |
| Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to NR1H4 mutation: A case report. | World J Clin Cases | 2021 | 34046462 | PubTator, text mining | PubMed |
| Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis. | JHEP Rep | 2021 | 34041468 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers. | Front Oncol | 2021 | 34026617 | PubTator, text mining | PubMed |
| Sensing Acute Cellular Rejection in Liver Transplant Patients Using Liver-Derived Extracellular Particles: A Prospective, Observational Study. | Front Immunol | 2021 | 34025656 | PubTator, text mining | PubMed |
| Cellular Mechanisms of Liver Fibrosis. | Front Pharmacol | 2021 | 34025430 | PubTator, text mining | PubMed |
| Monomeric bile acids modulate the ATPase activity of detergent-solubilized ABCB4/MDR3. | J Lipid Res | 2021 | 34022183 | PubTator, text mining | PubMed |
| Mutation Analysis and Disease Features at Presentation in a Multi-Center Cohort of Children With Monogenic Cholestasis. | J Pediatr Gastroenterol Nutr | 2021 | 34016879 | PubTator, text mining | PubMed |
| Transcriptome responses in polar cod (Boreogadus saida) liver slice culture exposed to benzo[a]pyrene and ethynylestradiol: insights into anti-estrogenic effects. | Toxicol In Vitro | 2021 | 34015484 | PubTator, text mining | PubMed |
| Benign recurrent intrahepatic cholestasis type 2 in a child: A case report and novel mutation. | Turk Arch Pediatr | 2021 | 34013234 | PubTator, text mining | PubMed |
| Direct Comparison of the Prediction of the Unbound Brain-to-Plasma Partitioning Utilizing Machine Learning Approach and Mechanistic Neuropharmacokinetic Model. | AAPS J | 2021 | 34008121 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5244/papers?page=43